NCT05178667已完成不适用
Effect of Carrot Seed and Rose Hip Extracts on Weight Management in Subjects With Overweight or Moderate Obesity. A Controlled, Randomized and Double-blind Study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 129
- 试验地点
- 4
- 主要终点
- Change from Baseline weight at 3 months
研究概览
简要总结
The aim of this study is to assess the effect of a food supplement containing extracts of carrot and rose hip seeds on the weight of volunteers with overweight or moderate obesity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 20 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •BMI between 25 and 35 kg / m² (limits excluded),
- •Having a fat mass (measured by impedance balance in kg) according to the following table:
- •Men 18-29 years : ≥ 21.2 kg; Men 30-49 years : ≥ 21.6 kg; Men 50-65 years : ≥ 23.8 kg; Women 18-29 years : ≥ 31.4 kg; Women30-49 years : ≥ 31.8 kg; Women 50-65 years : ≥ 33.9 kg.
- •Willing to observe dietetic plan in accordance with dietitian evaluation,
- •Able and willing to participate to the study by complying with the protocol procedures as evidenced by his dated and signed informed consent form,
- •Affiliated with a social security scheme.
排除标准
- •Dyslipidemia or hyperlipidemia:
- •Fasting total cholesterol ≥ 3.0 g / L
- •Fasting triglycerides> 2.5 g / L
- •with heterozygous familial hypercholesterolemia,
- •Diabetes treated or not with medication,
- •With severe hepatic and / or renal impairment, liver enzyme level (ALT and / or AST) greater than 2.5 times the upper normal limit,
- •TSH abnormal or not stable for at least 3 months,
- •History of cardiac disease (heart attack, stroke, coronary artery disease) or chronic inflammatory disease in the previous 6 months,
- •With cancer or having had cancer in the 3 years preceding the study, with the exception of basal cell cancers of the skin,
- •Taking drugs known to have an impact on weight management (corticosteroids, neuroleptics, anti-HIV triple therapy, etc.) in the month preceding inclusion and / or likely to consume them during the test,
- •Taking antibiotic therapy, anti-depressant treatment or treatment related to anxiety in the month preceding the study,
- •Taking anti-depressant treatment or treatment related to anxiety Subject in a state of depression,
- •Weight loss treatment in the previous 6 months or having followed a specific treatment promoting weight loss,
- •Non stable weight during the last 6 months (>5% change in total weight),
- •With metal implant (to allow DEXA measurement),
- •Blood donation in the month before the start of the study and during the study,
- •Consuming food supplements or functional foods known to have an influence on weight management in the month preceding the inclusion and / or likely to take during the test,
- •Following or having followed a hypocaloric diet (energy intake <1,500 kCal / day) in the month preceding inclusion and / or likely to undertake this diet during the test,
- •Following a particular diet (vegan),
- •Diagnosed eating disorders (bulimia, anorexia nervosa, vomiting),
- •Intense sport exercise practice (physical activity more than 4 hours per week) or not willing to maintain their exercise practises stable during the test,
- •Smoking more than 5 cigarettes per day, unstable cigarettes consumption, or smoking cessation during 6 months preceding the inclusion or during the test,
- •Bariatric surgery or who has a gastroplasty ring,
- •Consuming more than 2 (women) or 3 (men) standard drinks of alcoholic beverage daily,
- •Consuming illicit drugs,
- •Using topical anti-cellulite treatments,
- •For woman: Pregnant or planned to become, breastfeeding, with non-effective contraception,
- •Known allergy to one of the component of the supplement (carrot and rose hip),
- •Suffering from serious illnesses such as cancer, recent myocardial infarction, serious digestive pathologies or others diseases found to be inconsistent with the conduct of the study by the investigator,
- •Taking part in another clinical trial or being in the exclusion period of a previous clinical trial,
- •Under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision,
- •Presenting a psychological or linguistic incapability to sign the informed consent,
- •Any other condition which in the investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.
结局指标
主要结局
Change from Baseline weight at 3 months
时间窗: 0 month (inclusion), 3 months
Weight (unit: kg)
次要结局
- Transaminases(0 month (inclusion), 3 months)
- Sedimentation rate(0 month (inclusion), 3 months)
- Fasting glycemia(0 month (inclusion), 3 months)
- HbA1c(0 month (inclusion), 3 months)
- HOMA index(0 month (inclusion), 3 months)
- Lipid metabolism(0 month (inclusion), 3 months)
- Anthropometric parameters(0 month (inclusion), 1 month, 2 months, 3 months)
- Insulinemia(0 month (inclusion), 3 months)
- Body mass composition by DEXA (dual energy x-ray absorptiometry)(0 month (inclusion), 3 months)
- Free fatty acids(0 month (inclusion), 3 months)
- Hepatic metabolism(0 month (inclusion), 3 months)
- Blood count(0 month (inclusion), 3 months)
- Thyroid Stimulating Hormone(0 month (inclusion), 3 months)
- High sensible C-reactive protein(0 month (inclusion), 3 months)
- Heart rate(0 month (inclusion), 1 month, 2 months, 3 months)
- Blood pressure(0 month (inclusion), 1 month, 2 months, 3 months)
- Weight(0 month (inclusion), 1 month, 2 months, 3 months)
- Body mass composition by impedancemetry(0 month (inclusion), 1 month, 2 months, 3 months)
- Height(0 month (inclusion), 1 month, 2 months, 3 months)
- Body Mass Index(0 month (inclusion), 1 month, 2 months, 3 months)
研究者
Jean-Michel Lecerf
Principal investigator
Institut Pasteur de Lille
研究点 (4)
Loading locations...
相似试验
尚未招募
Unknown
Effects of plant-extracts containing foods on circulatory systemot applicableJPRN-UMIN000053408Other30
已完成
不适用
Impacts of a Combined Berry Extract Supplement on Vascular Function and Oxygen Utility Capacity in Young AdultsHealthyNCT04312022University of Nebraska18
已完成
不适用
Effect of a plant extract containing dietary supplement on psychopathologic stress reactions among healthy participantsDRKS00006008Schaper & Brümmer GmbH & Co. KG65
已完成
2 期
Assessing effect of antioxidant enriched foods in Indian adultsCTRI/2015/01/005402ICMR75
已完成
不适用
A study of effect of food containing plant ingredient on skin temperatureJPRN-UMIN000031738Kirin Company, Limited15